| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 61, 1214-1216, Copyright © 1985 by Endocrine Society
ARTICLES |
EA Lane and HB Moss
Hepatic clearance concepts were applied to existing data on iv and oral administration of melatonin to man. A high hepatic extraction ratio was calculated, suggesting prominent first pass hepatic metabolism and reduced bioavailability for orally administered melatonin. Using clearance parameters and previous data, endogenous production rates for melatonin were determined for normal individuals and patients with cirrhosis. Normal melatonin production was 28.8 micrograms/day, while the production rate for cirrhotic patients was 12.3 micrograms/day. Thus, not only do cirrhotic patients have decreased melatonin elimination, as noted in the original report, but they also have decreased daily melatonin production.
This article has been cited by other articles:
 |
|
 |
|
  S. L. Markantonis, E. Tsakalozou, A. Paraskeva, C. Staikou, and A. Fassoulaki Melatonin Pharmacokinetics in Premenopausal and Postmenopausal Healthy Female Volunteers J. Clin. Pharmacol., February 1, 2008; 48(2): 240 - 245. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Gomez-Pinilla, P. J. Camello, and M. J. Pozo Effects of Melatonin on Gallbladder Neuromuscular Function in Acute Cholecystitis J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 138 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Naguib, A. H. Samarkandi, M. A. Moniem, E. E.-D. Mansour, A. A. Alshaer, H. A. Al-Ayyaf, A. Fadin, and S. W. Alharby The Effects of Melatonin Premedication on Propofol and Thiopental Induction Dose-Response Curves: A Prospective, Randomized, Double-Blind Study Anesth. Analg., December 1, 2006; 103(6): 1448 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Gomez-Pinilla, C. Camello-Almaraz, R. Moreno, P. J. Camello, and M. J. Pozo Melatonin Treatment Reverts Age-Related Changes in Guinea Pig Gallbladder Neuromuscular Transmission and Contractility J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 847 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Mahmoud, N. Sarhill, and M. A. Mazurczak The therapeutic application of melatonin in supportive care and palliative medicine American Journal of Hospice and Palliative Medicine, July 1, 2005; 22(4): 295 - 309. [Abstract] [PDF]
|
|
|
|
 |
|
 Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kovács, W. Brodner, V. Kirchlechner, T. Arif, and F. Waldhauser Measurement of Urinary Melatonin: A Useful Tool for Monitoring Serum Melatonin after Its Oral Administration J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 666 - 670. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. J. Van Den Heuvel, D. J. Kennaway, and D. Dawson Effects of daytime melatonin infusion in young adults Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E19 - E26. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
